RxDoctor Payments Data

Rose Langer, MD

Family Medicine · Trinity, FLNPI 1659320364

Payments from drug & device makers

$323in general payments, 2019–2025

Across 12 payments — averaging $26.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$103
  • Exact Sciences$66
  • Novo Nordisk$47
  • Lilly USA, LLC$28
  • AstraZeneca$26
  • Abbott$20
  • plus $34 from 2 others

What the payments were for

  • Food & beverage$323100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)2$103
Exact Sciences1$66
Novo Nordisk2$47
Lilly USA, LLC2$28
AstraZeneca2$26
Abbott1$20
AbbVie1$18
Novartis1$16

How this compares

$323 in reported general payments places this provider in the 40th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$56,468
Medicare patients
128
Services billed
494

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin75$102,584
OzempicSemaglutide29$54,443
FarxigaDapagliflozin Propanediol35$46,620
JanuviaSitagliptin Phosphate22$34,152
TrulicityDulaglutide14$19,511
Trelegy ElliptaFluticasone/Umeclidin/Vilanter15$15,691
EliquisApixaban13$14,439
SymbicortBudesonide/Formoterol Fumarate18$10,167
Stiolto RespimatTiotropium Br/Olodaterol Hcl16$7,389
Tresiba Flextouch U-100Insulin Degludec17$7,251
Atorvastatin Calcium576$4,499
Rosuvastatin Calcium298$3,291
Levothyroxine Sodium284$2,778
Albuterol Sulfate HfaAlbuterol Sulfate74$2,710
Omeprazole204$2,662

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Symbicort$26$56,78753 claims
Novo NordiskOzempic$47$54,44329 claims
Lilly USA, LLCTrulicity$28$19,51114 claims
AbbVieSynthroid$18$1,42126 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Trinity

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →